首页|2012和2021版CKD-EPI肾小球滤过率公式在2~3期慢性肾病患者中的应用研究

2012和2021版CKD-EPI肾小球滤过率公式在2~3期慢性肾病患者中的应用研究

扫码查看
目的:比较 2012和 2021版慢性肾脏病流行病学合作研究(CKD-EPI)肾小球滤过率公式在 2~3期慢性肾病患者中的应用研究。方法:选取 2022年 4月—2024年 3月齐齐哈尔市第一医院南院收治的100例 2~3期慢性肾病患者为研究对象,对所有患者测定GFR参考值(rGFR)、血清肌酐(Ser)和胱抑素C(Cys C),并分别采用 2012和 2021版CKD-EPI肾小球滤过率公式计算GFR估算值(eGFR),分析两版公式计算出的eGFR与rGFR的一致性。结果:4个公式计算出的eGFR与rGFR均大致呈线性关系。两版CKD-EPI Scr-Cys C公式得到的MSE值均小于CKD-EPI Scr公式得到的MSE值,且 2012版CKD-EPI Scr-Cys C公式得到的MSE值小于 2021版,差异均有统计学意义(P<0。05)。两版CKD-EPI Scr-Cys C公式得到的曲线下面积(AUC)均大于CKD-EPI Scr公式得到的AUC值,且 2012版CKD-EPI Scr-Cys C公式得到的AUC值大于 2021版,差异均有统计学意义(P<0。05)。Bland-Altman分析结果显示,2012版 CKD-EPI Scr-Cys C公式偏差和精确度最小,2021版 CKD-EPI Scr偏差和精确度最大,差异均有统计学意义(P<0。05);分析 15%、30%和 50%rGFR范围内的eGFR值发现,CKD-EPI Scr-Cys C公式高于CKD-EPI Scr公式,且 2012版的 2个公式均高于 2021版。对 4个公式计算出的eGFR值与rGFR值的分期诊断效能进行Kappa检验分析,结果显示,2012版CKD-EPI Scr-Cys C公式具有最高的分期诊断准确度与Kappa值,分期诊断效能最好;两版CKD-EPI Scr-Cys C公式相比CKD-EPI Scr公式具有更高的诊断准确度与Kappa值,分期诊断效能较好,差异均有统计学意义(P<0。05)。结论:对 2~3期慢性肾病患者,2012版CKD-EPI Scr-Cys C公式适用性更高,分期诊断效能最好;2012和2021版CKD-EPI Scr-Cys C公式比CKD-EPI Scr公式分期诊断效能更好。
Application of 2012 and 2021 CKD-EPI Glomerular Filtration Rate Formula in Patients with Stage 2 to 3 Chronic Kidney Disease
Objective:To compare the application of glomerular filtration rate formula in patients with stage 2~3 chronic kidney disease(CKD-EPI)in the 2012 and 2021 Collaborative Study on Epidemiology of Chronic Kidney Disease(CKD-EPI).Methods:A total of 100 patients with stage 2~3 chronic kidney disease admitted to the South Hospital of Qiqihar First Hospital from April 2022 to March 2024 were selected as the study objects.GFR reference value(rGFR),serum creatinine(Ser)and cystatin C(Cys C)were determined for all patients.The 2012 and 2021 CKD-EPI glomerular filtration rate formulas were used to calculate the estimated GFR(eGFR),and the consistency of eGFR and rGFR calculated by the two formulas was analyzed.Results:The relationship between eGFR and rGFR calculated by the four formulas was roughly linear.The MSE value obtained by the two CKD-EPI Scr-Cys C formula was smaller than that obtained by the CKD-EPI Scr formula,and the MSE value obtained by the 2012 CKD-EPI Scr-Cys C formula was smaller than that obtained by the 2021 CKD-EPI Scr C formula,with statistical significance(P<0.05).The area under the curve(AUC)value obtained by the two CKD-EPI Scr-Cys C formulas was greater than that obtained by the CKD-EPI Scr formula,and the AUC value obtained by the 2012 CKD-EPI Scr-Cys C formula was greater than that obtained by the 2021 CKD-EPI Scr C formula,with statistical significance(P<0.05).Bland-Altman analysis results showed that the 2012 CKD-EPI Scr-Cys C formula had the smallest deviation and accuracy,while the 2021 CKD-EPI Scr formula had the largest deviation and accuracy,the differences were statistically significant(P<0.05).Analysis of eGFR values in the rGFR ranges of 15%,30%and 50%showed that the CKD-EPI Scr-Cys C formula was higher than the CKD-EPI Scr formula,and two formulas of the 2012 version were higher than those of the 2021 version.Kappa test was performed to analyze the staging diagnostic efficiency of eGFR values and rGFR values calculated by the four formulas.The results showed that the 2012 version of CKD-EPI Scr-Cys C formula had the highest staging diagnostic accuracy and Kappa value,and the staging diagnostic efficiency was the best.Compared with the Scr formula,the two versions of CKD-EPI Scr-Cys C formula had higher diagnostic accuracy and Kappa value,and better stage diagnosis efficiency,with statistical significance(P<0.05).Conclusion:The 2012 version of CKD-EPI Scr-Cys C formula is more suitable for stage 2~3 chronic kidney disease patients,and has the best stage diagnosis efficiency.The 2012 and 2021 versions of CKD-EPI Scr-Cys C formula are better than CKD-EPI Scr formula in staging diagnosis.

Chronic kidney diseaseCKD-EPI glomerular filtration rate formulaApplicability

周敬富

展开 >

齐齐哈尔市第一医院南院肾内一科,黑龙江 齐齐哈尔 161000

慢性肾病 CKD-EPI肾小球滤过率公式 适用性

2024

中国伤残医学
中国康复医学会,黑龙江省截瘫研究所

中国伤残医学

影响因子:0.451
ISSN:1673-6567
年,卷(期):2024.32(19)